– UK, London – Alchemab Therapeutics, a biotechnology company focused on the discovery and development of naturally-occurring protective antibodies in neurodegeneration and oncology, today announced the appointment of Dr.…
– USA, CA – Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today the appointment of Dr.…
– USA, CA – Biosplice Therapeutics, Inc., a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for major diseases, today announced the addition of Dave Johnson, most recently Founder and CEO of VelosBio, to its Board as an independent director.…
– USA, CA – 23andMe Holding Co. (Nasdaq: ME), leading consumer genetics and research company, today announced the appointment of Dr.…
– USA, NC – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the appointment of Alicia Secor to its Board of Directors.…